XTL is an IP Portfolio company that holds 100% of The Social Proxy Ltd. and IP portfolio including hCDR1 for Lupus (SLE) and Sjögren's Syndrome (SS) that the company sublicensed. The company actively ...
XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced that it is working diligently to close the acquisition ...
Results Summary Change Change vs Dollars in millions (except per vs 4Q25 3Q25 3Q25 share data) 2025 2024 2024 6,501 7,548 -1,047 Earnings (U.S. GAAP) 28,844 33,680 -4,836 Earnings Excluding Identified ...
Iran’s praetorian guard that the United States has designated as a foreign terrorist organization, conducted a coordinated ...
In 2025, many courts assessing claims under the federal Wiretap Act confronted a common fact pattern—use of modern ...
Discover the top 4 undervalued Health Care Providers & Services stocks for Thursday, January 29 based on AAII’s Stock Grades.
Securities Portfolio -- Increased $147.9 million or 5.8% to $2.70 billion, based on $373 million in mainly MBS purchases, offsetting $82 million in municipal securities sales plus maturities/payments; ...